Antibiotic allergy labels in immunocompromised populations

Area of Science:

• Clinical Medicine
• Immunology
• Pharmacology

Background:

• Antibiotic allergy labels (AALs) are frequently documented in the general population.
• There is growing research interest in the prevalence and impact of AALs specifically within immunocompromised patient populations.
• These patients often have high antibiotic utilization, making AALs a significant clinical consideration.

Purpose of the Study:

• To review the current literature on the prevalence and impact of AALs in immunocompromised hosts.
• To discuss methods for evaluating antibiotic allergy and strategies for antibiotic allergy delabeling in this population.
• To focus on beta-lactam (penicillin) and sulfa-antibiotic allergy labels.

Main Methods:

• Systematic review of existing literature.
• Analysis of studies focusing on immunocompromised hosts.
• Examination of antibiotic allergy evaluation and delabeling techniques.

Main Results:

• AALs are prevalent in immunocompromised individuals.
• Effective evaluation and delabeling strategies can optimize antibiotic use.
• Specific focus on beta-lactam and sulfa allergies provides targeted insights.

Conclusions:

• Understanding AALs in immunocompromised hosts is crucial for improving patient care.
• Delabeling strategies hold significant potential to enhance antibiotic prescribing practices.
• Further research into evaluation methods can lead to better clinical outcomes.